The Propark study is coordinated by the Leiden University Medical Center, Department of Neurology, Leiden, The Netherlands
 
SCOPA BACKGROUND
SCOPA SCALES
PROPARK BACKGROUND
LIST OF PUBLICATIONS
RESEARCH TEAM
PROJECTS
FINANCIAL SUPPORT
PROMISE DATABASE

E-MAIL
CONTACT
LOGIN

HOMEPAGE

© developed by dick jeukens
Publication
Titles and texts are only in English available.
Authors

Tijero B, Gomez-Esteban JC, Llorens V, Lezcano E, Gonzalez-Fernández MC, de Pancorbo MM, Ruiz-Martinez J, Cembellin JC, Zarranz JJ.

Title
Cardiac sympathetic denervation precedes nigrostriatal loss in the E46K mutation of the alpha-synuclein gene (SNCA).
Published in:
Clin Auton Res. 2010 May 5. [Epub ahead of print]
Content

INTRODUCTION: Here we report the case of an asymptomatic carrier of the E46K substitution in alpha-synuclein gene where we have documented that cardiac sympathetic denervation precedes nigrostriatal dopaminergic loss. MATERIAL AND METHODS: She has been followed up regularly with standard neurological examination, UPDRS, neuropsychological formal testing, parkinson disease sleep scale-PDSS, Epworth scale, Hamilton-D scale, SCOPA Aut, orthostatic hypotension test, brief smell identification test, polysomnography, cerebral 123-I-FP-CIT SPECT, and, 123I-MIBG cardiac scintigraphy. RESULTS: She shows no presence of orthostatic hypotension. Olfactory test results demonstrate normal limits. In the PSG the nocturnal sleep shows mild abnormalities although the sleep efficiency and stage proportion remain under normal limits. The 123-I-FP-CIT SPECT is normal; in contrast, the 123I-MIBG cardiac scintigraphy shows a complete lack of isotopic uptake compatible with a severe sympathetic myocardial denervation. CONCLUSION: This example of monogenic autosomal dominant parkinsonism due to an alpha-synuclein mutation favours the hypothesis that peripheral autonomous nervous system involvement occurs earlier than the CNS degeneration.

Publications by other groups using SCOPA scales
List of publications
  Publications in 2010
Autonomic and cognitive functions in Parkinson's disease (PD).
Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease.
Cardiac sympathetic denervation precedes nigrostriatal loss in the E46K mutation of the alpha-synuclein gene (SNCA).
Cross-cultural evaluation of the modified Parkinson Psychosis Rating Scale across disease stages.
Heart rate variability in type 2 spinocerebellar ataxia.
Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease.
Psychometric properties of the SCOPA-AUT Brazilian Portuguese version.
Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease.
What contributes to driving ability in Parkinson's disease.

  Publications in 2009
Addenbrooke's Cognitive Examination validation in Parkinson's disease.
Assessing autonomic symptoms of Parkinson's disease with the SCOPA-AUT: a new perspective from Rasch analysis.
Cognitive impairment in Parkinson's disease: Tools for diagnosis and assessment.
Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease.
Exercise therapy, quality of life, and activities of daily living in patients with Parkinson disease: a small scale quasi-randomised trial.
Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease
Independent validation of the scales for outcomes in Parkinson's disease-autonomic (SCOPA-AUT).
International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.
Psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale. An independent validation study
Psychometric attributes of the Scales for Outcomes in Parkinson's Disease-Psychosocial (SCOPA-PS): validation in Spain and review
Should the SCOPA-COG be modified?: a Rasch analysis perspective.
The Clinical Impression of Severity Index for Parkinson's Disease: international validation study.

  Publications in 2008
Burden, perceived health status, and mood among caregivers of Parkinson's disease
Cross-Cultural Validation of the Scales for Outcomes in Parkinson's
Does implicit learning in non-demented Parkinson's disease depend on the level of cognitive functioning?
Longitudinal psychometric attributes, responsiveness, and importance of change:
Psychometric attributes of Scales for Outcomes in Parkinson's Disease-Cognition (SCOPA-Cog), Castilian language
Psychometric attributes of the SCOPA-COG Brazilian version.

  Publications in 2007
Anxiety and depression: Main determinants of health-related quality of life in
Autonomic and Cognitive dysfunction in Parkinson's disease.
Caregiver burden in Parkinson's disease.
Determinants of quality of life in Brazilian patients with Parkinson's disease.
Dopamine: so last century
Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version.
Sleep disorders in Parkinson's disease: facts and new perspectives.

  Publications in 2006
A longitudinal study of patients with Parkinson's disease (ELEP): aims and methodology (article in spanish)
A pilot study on a specific measure for sleep disorders in Parkinson's disease: SCOPA-Sleep
No correlation between the clinical severity of autonomic symptoms (SCOPA-AUT) and electrophysiological test abnormalities in advanced Parkinson's disease

  Publications in 2005
The SCOPA-Motor Scale for assessment of Parkinson's disease is a consistent and valid measure.